Josep Vergés

Summary

Publications

  1. ncbi Weather conditions can influence rheumatic diseases
    Josep Vergés
    Scientific Medical Department, Bioibérica Farma, Plaza Francesc Macia 7, 08029 Barcelona, Spain
    Proc West Pharmacol Soc 47:134-6. 2004
  2. ncbi Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study
    Steeve Kwan Tat
    Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre Dame Hospital, 1560 rue Sherbrooke Est, Montreal, Quebec H2L 4M1, Canada
    Arthritis Res Ther 9:R117. 2007
  3. ncbi [Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases]
    Josep Vergés
    Unidad de Investigacion Clinica, Departamento Médico y Científico, Bioibérica, S A, Barcelona, Spain
    Med Clin (Barc) 123:739-42. 2004
  4. ncbi On the bioavailability of oral chondroitin sulfate formulations: proposed criteria for bioequivalence studies
    Josep Vergés
    Bioibérica, Scientific Medical Department, Plaza Francesc Macia 7, 08029 Barcelona, Spain
    Proc West Pharmacol Soc 47:50-3. 2004
  5. ncbi Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding
    Josep Vergés
    Clinical Research Unit, Scientific Medical Department, Bioibérica, S A, Barcelona, Spain
    Dermatol Online J 11:31. 2005

Collaborators

  • Steeve Kwan Tat
  • Jean-Pierre Pelletier
  • Johanne Martel-Pelletier
  • Daniel Lajeunesse
  • Jean Pierre Pelletier
  • Eulalia Montell
  • Martin Lavigne
  • Hassan Fahmi

Detail Information

Publications5

  1. ncbi Weather conditions can influence rheumatic diseases
    Josep Vergés
    Scientific Medical Department, Bioibérica Farma, Plaza Francesc Macia 7, 08029 Barcelona, Spain
    Proc West Pharmacol Soc 47:134-6. 2004
    ....
  2. ncbi Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study
    Steeve Kwan Tat
    Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre Dame Hospital, 1560 rue Sherbrooke Est, Montreal, Quebec H2L 4M1, Canada
    Arthritis Res Ther 9:R117. 2007
    ..This was confirmed by the decreased resorptive activity for the combination of CS and GS. These data are of major significance and may help to explain how these two drugs exert a positive effect on OA pathophysiology...
  3. ncbi [Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases]
    Josep Vergés
    Unidad de Investigacion Clinica, Departamento Médico y Científico, Bioibérica, S A, Barcelona, Spain
    Med Clin (Barc) 123:739-42. 2004
    ..We describe the clinical and histopathological results of the erythematous and desquamative plaques of three patients with osteoarthritis and psoriasis treated with chondroitin sulfate...
  4. ncbi On the bioavailability of oral chondroitin sulfate formulations: proposed criteria for bioequivalence studies
    Josep Vergés
    Bioibérica, Scientific Medical Department, Plaza Francesc Macia 7, 08029 Barcelona, Spain
    Proc West Pharmacol Soc 47:50-3. 2004
    ..8-1.2, both CS formulations can be considered as bioequivalent. In the absence of such bioequivalence studies, physicians and patients are advised to use the reference product to obtain the maximal benefit in terms of efficacy and safety...
  5. ncbi Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding
    Josep Vergés
    Clinical Research Unit, Scientific Medical Department, Bioibérica, S A, Barcelona, Spain
    Dermatol Online J 11:31. 2005
    ....